DA Davidson lowered the firm’s price target on BlueLinx (BXC) to $75 from $80 and keeps a Neutral rating on the shares. The stock traded modestly lower since reporting Q2 results despite a better than feared performance in a tough environment, the analyst tells investors in a research note. The silver linings for BlueLinx included y/y volume gains in both segments, fueled in part by execution within multi-family, as well as a relatively stable gross margin performance in Specialty Products, the firm added.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BXC:
